MALAT1 and hepatocellular carcinoma: Furthermore, an endosomal pH‐responsive nanoparticle platform designed for codelivery of siRNA and a cisplatin prodrug specifically transports siRNA into the nucleus, reversing cisplatin resistance by silencing nuclear‐localized MALAT1 and inhibiting HCC tumor growth [620].